Brand and Promotional Analysis

Brand and Promotional Analysis
Product Description

Powered by the IQVIA CORE™, our promotional analysis can help you understand the trajectory of your brand and measure its progress along the way. We can help you see where you are today, where you’re going and help you make adjustments as part of your path forward. Find out what you need to know about Share of voice Message recall Threats to your brand from competitors Channel effectiveness — from your advertising to your sales force Your net promoter score, and more Our solutions are designed to help you plan, measure and adapt your promotional strategy and its impact on your brand.

Read more Show less

IQVIA

  • CH
  • 2018
    On CPHI since
View company profile
Categories
more categories Show less
Sales Markets
Show more Show less

IQVIA

  • CH
  • 2018
    On CPHI since
View company profile

More Products from IQVIA (2)

  • Managed Markets Data & Analytic Solutions

    Product Managed Markets Data & Analytic Solutions

    Fundamental to the success of your market access strategy is clear visibility into payer, provider and patient behavior. IQVIA’s comprehensive real-world database includes lifecycle transactions, which offer the critical level of detail required to untangle the complex interaction of payer utilization ...
  • Launch Performance by Patient Segment

    Product Launch Performance by Patient Segment

    Each launch has a million moving pieces. Almost all are based on what you know about your market. Which patients are using which products? What is their patient journey? What types of physicians prescribe them? How do treatments and costs vary by geography or provider? Primary market research provides ...

IQVIA resources (1)

  • Cost and volume pressures giving rise to value-added medicines: IQVIA

    News Cost and volume pressures giving rise to value-added medicines: IQVIA

    Rising pharmaceutical cost pressures and volume growth deceleration are forcing pharmaceutical companies to attempt to extract further value from existing medicines rather than solely pursuing new molecules, according to Aurelio Arias, Engagement Manager, European Thought Leadership, IQVIA.
    10 Feb 2020